Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis

Cancer Letters

Volumn 283, Issue 1, 2009, Pages 84-91

  Shi, Wei Dong ^a   Meng, Zhi Qiang ^a   Chen, Zhen ^a   Lin, Jun Hua ^a   Zhou, Zhen Hua ^a   Liu, Lu Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gene expression profiling; Liver metastasis; Metastasis related genes; Microarray; Pancreatic cancer

Indexed keywords

ALPHA7 INTEGRIN; CHEMOKINE RECEPTOR CXCR2; GELATINASE B; GLYCOSYLTRANSFERASE; MATRILYSIN; PROTEIN MDM2; PROTEIN MGAT5; SCATTER FACTOR RECEPTOR; SOMATOMEDIN; SOMATOSTATIN RECEPTOR 2; STROMELYSIN 2; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; LIVER METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PANCREAS CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 67650462241     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.030     Document Type: Article

References (40)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics. CA Cancer J. Clin. 54 (2004) 8-29
2. Shishido T., Yasoshima T., Hirata K., et al. Establishment and characterization of human pancreatic carcinoma lines with a high metastatic potential in the liver of nude mice. Surg. Today 29 (1999) 519-525
3. Vezeridis M.P., Tzanakakis G.N., Meitner P.A., et al. In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse. Cancer 69 (1992) 2060-2063
4. Nishimori H., Yasoshima T., Hata F., Denno R., Yanai Y., et al. A novel nude mouse model of liver metastasis and peritoneal dissemination from the same human pancreatic cancer line. Pancreas 24 (2002) 242-250
5. Bruns C.J., Harbison M.T., Kuniyasu H., Eue I., and Fidler I.J. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1 (1999) 50-62
6. Kyriazis A.P., McCombs III W.B., Sandberg A.A., Kyriazis A.A., Sloane N.H., and Lepera R. Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. Cancer Res. 43 (1983) 4393-4401
7. Fidler I.J. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metast. Rev. 29 (1986) 29-49
8. Giavazzi R., Campbell D.E., Jessup J.M., Cleary K., and Fidler I.J. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res. 469 (1986) 1928-1933
9. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., and McEwan. RNA rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47 (1987) 3239-3245
10. Patterson Jr. M.K. Measurement of growth and viability of cells in culture. In: Jakoby W.B., and Pastin I.H. (Eds). Methods in Enzymology vol. 58 (1979), Academic Press Inc., New York 141-152
11. Fan D., Bucana C.D., O'Brian C.A., Zwelling L.A., Seid C., and Fidler I.J. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes. Cancer Res. 50 (1990) 3619-3626
12. Liao Y., Tang Z.Y., Ye S.L., Liu K.D., Sun F.X., and Huang Z. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20. Hepato-Gastroenterology 47 (2000) 365-370
13. Denno R., Yasoshima T., Hirata K., et al. Tumorigenicity motility and liver metastasis of human gastric carcinoma lines with high metastatic potential in the liver of the nude mice. Tumor Res. 30 (1996) 57-65
14. Sakurai Y., Sawada T., Chung Y.S., et al. Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis. Clin. Exp. Metast. 15 (1997) 307-317
15. Morikawa K., Walker S.M., Jessup J.M., and Fidler I.J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colorectal carcinomas implanted into nude mice. Cancer Res. 48 (1988) 1943-1948
16. Li Y., Tang Z.-Y., Ye S.-L., Liu Y.-K., Chen J., et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J. Gastroenterol. 7 (2001) 630-636
17. Wei D., Xiong H.Q., Abbruzzese J.L., Xie K., et al. Experimental animal models of pancreatic carcinogenesis and metastasis. Int. J. Gastrointest. Cancer 33 (2003) 43-60
18. Yasoshima T., Denno R., Kawaguchi S., Sato N., Okada Y., Ura H., Kikuchi K., and Hirata K. Establishment of human gastric carcinoma lines with high metastatic potential in the liver: changes in integrin expression associated with the ability to metastasize in the liver of nude mice. Jpn. J. Cancer Res. 87 (1996) 153-160
19. Samiei M., and Waghorne C.G. Clonal selection within metastatic SPI mouse mammary tumors is independent of metastatic potential. Int. J. Cancer. 47 (1991) 771-775
20. Suzuki N., Frapart M., Grdina D.J., Meistrich M.L., Whiters H.R., et al. Cell cycle dependency of metastatic lung colony formation. Cancer Res. 37 (1977) 3690-3693
21. Price J.E., Bell C., and Frost P. The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice. Int. J. Cancer 45 (1990) 968-971
22. Nakamura T., Fidler I.J., and Coombes K.R. Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res. 67 (2007) 139-148
23. Caldeira J.R., Prando E.C., Quevedo F.C., Neto F.A., Rainho C.A., and Rogatto S.R. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 6 (2006) 1471-2407
24. Besterman J.M., and Low R.B. Endocytosis: a review of mechanisms and plasma membrane dynamics. Biochem. J. 210 (1983) 1-13
25. Partridge E.A., Le R.C., Di G.G.M., Pawling J., Cheung P., Granovsky M., et al. Regulation of cytokine receptors by golgi N-glycan processing and endocytosis. Science 306 (2004) 120-124
26. Liu J.P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A.A. A mice carrying null mutations of the genes encoding insulin-like growth factor 1 (IGF1) and type 1 IGF receptor (IGF1r). Cell 75 (1993) 59-72
27. DeAngelis T., Ferber A., and Baserga R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol. 164 (1995) 214-221
28. Coppola D., Ferber A., Miura M., Sell C., D'Ambrosio C., Rubin R., and Baserga R. A functional IGF1 receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14 (1994) 4588-4595
29. Naldini L., Weidner K.M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Michalopoulos G.K., et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. Eur. Mol. Biol. Org. J. 10 (1991) 2867-2878
30. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., and Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
31. Christensena J.G., Burrowsc J., and Salgia R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 225 (2005) 1-26
32. Epstein R.J. VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic. Cancer Metast. Rev. 26 (2007) 443-452
33. Tomioka D., Maehara N., Kuba K., Mizumoto K., Tanaka M., Matsumoto K., and Nakamura T. Inhibition of growth, invasion and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res. 61 (2001) 7518-7524
34. Marchesi F., Monti P., Leone B.E., Zerbi A., Vecchi A., Piemonti L., Mantovani A., and Allavena P. Increased survival, proliferation and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res. 64 (2004) 8420-8427
35. Chu C.S., Xue B., Tu C., Feng Z.H., Shi Y.H., Miao Y., and Wen C.J. NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo. Cancer Lett. 250 (2007) 268-275
36. Cox G., and O'Byrne K.J. Matrix metalloproteinases and cancer. Anticancer Res. 21 (2001) 4207-4219
37. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Ann. Rev. Cell Dev. Biol. 17 (2001) 463-516
38. Johansson N., Ahonen M., and Kähäri V.M. Matrix metalloproteinases in tumor invasion. Cell Mol. Life Sci. 57 (2000) 5-15
39. Tanno S., Mitsuuchi Y., Altomare D.A., Xiao G.H., and Testa J.R. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 61 (2001) 589-593
40. Paciucci R., Vila M.R., Adell T., et al. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. Am. J. Pathol. 153 (1998) 201-212